News
FDA Suspends U.S. License of Chikungunya Vaccine
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after reports of serious side effects in older adults similar to the symptoms of chikungunya virus.
FDA suspends license for chikungunya vaccine Ixchiq over serious safety concerns
The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker Valneva's chikungunya vaccine, saying that continued administration of the vaccine to the public would pose a danger to health.
Health agencies recommend wearing insect repellent and loose-fitting clothing to prevent bites from mosquitoes carrying the ...
Mosquito-borne chikungunya virus has caused an outbreak in China, but public health experts say the risk for spread and ...
An outbreak of the mosquito-borne virus in southern China has led to a pandemic-style response as authorities try to contain ...
Health and Me on MSN9h
Chikungunya Vaccine License Suspended In U.S. By FDA
The U.S. FDA has suspended the license for Valneva’s chikungunya vaccine Ixchiq after reports of severe side effects, ...
The cities of Foshan and Guangzhou, in southern China, have been battling the virus for two months. Nearly 10,000 cases have ...
DEAR DR. ROACH: I have a friend who lives in Paraguay and had been diagnosed with chikungunya. It has been extremely painful ...
Dear J.: Chikungunya may not sound like a real medical condition, but it is a viral disease that was first found in West ...
The war against the chikungunya virus that claims lives, which is dominant along the country’s coastal towns, has suffered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback